ilmscore | Prediction Details
By Stock Market Live | July 30, 2024 | Pending
Interpreted Prediction
The first phase of Pfizer's (PFE) manufacturing optimization program is expected to deliver approximately $1.5 billion in savings by the end of 2027, with some savings anticipated to be realized starting in 2025.

Prediction Details

Ticker

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.